Sens. Back Long-Term Protections For Biologic Drugs
In the tug-of-war over how to regulate generic versions of biologic treatments, a group of senators has joined the faction pulling for a full 12-year term of data exclusivity, saying the...To view the full article, register now.
Already a subscriber? Click here to view full article